Discover
PACB
Pacific Biosciences of California, Inc.
2.33
6 x 2.17
10 x 2.45
bid
ask
+
0.03
1.30%
8 @ 07:30 PM
2.32 -0.01 (0.43%)
| Ytd | 24.60% | |
| 1y | 52.29% |
2.21
day range
2.47
1.11
52 week range
2.87
| Open | 2.35 | Prev Close | 2.30 | Low | 2.21 | High | 2.47 | Mkt Cap | 724.24M |
| Vol | 12.82M | Avg Vol | 10.39M | EPS | -0.44 | P/E | N/A | Forward P/E | -2.84 |
| Beta | 2.01 | Short Ratio | 4.46 | Inst. Own | 84.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1.52 | 200-d Avg | 1.59 | 1yr Est | 3.02 |
| Income Statement | |||
| Total Revenue | 39.01M | ||
| Revenues (USD) | 39.01M | ||
| Cost of Revenue | 26.37M | ||
| Gross Profit | 12.64M | ||
| Operating Expenses | 57.25M | ||
| Research and Development Expense | 23.02M | ||
| Selling, General and Administrative Expense | 33.39M | ||
| Operating Income | -44.61M | ||
| Interest Expense | 2.11M | ||
| Income Tax Expense | 58.00K | ||
| Net Income | -44.74M | ||
| Net Income Common Stock | -44.74M | ||
| Net Income Common Stock (USD) | -44.74M | ||
| Consolidated Income | -44.74M | ||
| Earnings per Basic Share | -0.14 | ||
| Earnings per Basic Share (USD) | -0.14 | ||
| Earnings per Diluted Share | -0.14 | ||
| Earning Before Interest & Taxes (EBIT) | -42.57M | ||
| Earning Before Interest & Taxes (USD) | -42.57M | ||
| Weighted Average Shares | 310.65M | ||
| Weighted Average Shares Diluted | 310.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 61.04M | ||
| Cash and Equivalents (USD) | 61.04M | ||
| Investments | 177.44M | ||
| Investments Current | 175.87M | ||
| Investments Non-Current | 1.57M | ||
| Trade and Non-Trade Receivables | 31.10M | ||
| Current Assets | 338.64M | ||
| Property, Plant & Equipment Net | 67.30M | ||
| Total Assets | 751.85M | ||
| Debt Current | 1.37M | ||
| Total Debt | 706.13M | ||
| Current Liabilities | 68.81M | ||
| Debt Non-Current | 704.76M | ||
| Total Liabilities | 785.06M | ||
| Accumulated Retained Earnings (Deficit) | -2.75B | ||
| Accumulated Other Comprehensive Income | -503.00K | ||
| Shareholders Equity | -33.21M | ||
| Shareholders Equity (USD) | -33.21M | ||
| Assets Non-Current | 413.21M | ||
| Total Debt (USD) | 706.13M | ||
| Deferred Revenue | 19.44M | ||
| Goodwill and Intangible Assets | 330.85M | ||
| Inventory | 61.08M | ||
| Liabilities Non-Current | 716.26M | ||
| Trade and Non-Trade Payables | 19.22M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.01M | ||
| Net Cash Flow from Financing | 255.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.74M | ||
| Capital Expenditure | -1.55M | ||
| Issuance (Purchase) of Equity Shares | 255.00K | ||
| Net Cash Flow from Investing | 40.07M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 43.68M | ||
| Net Cash Flow from Operations | -35.58M | ||
| Share Based Compensation | 9.26M | ||